U Faculty Calls
for Review of Controversial Drug Study
Jeremy Olson, Star Tribune
"Nearly a decade after
Dan Markingson died by suicide while participating in a U of M drug trial for
schizophrenics, the U’s Faculty Senate raised his death as a reason to
re-examine their institution’s handling of vulnerable research
Make Your Wishes Known
Ashwaq Masoodi, The Atlantic
"The story of a 36-year-old man on life support whose family pulled the plug, and what happened next."
Thomas Insel, National Institute of Mental Health
"While DSM has been described as a “Bible” for the field, it is, at best, a dictionary, creating a set of labels and defining each."
As Harvard Closes a Primate Research Center, Are Lab Chimps Becoming a Thing of the Past?
Bryan Walsh, TIME
"While there is real benefit to primate research, it will need to be balanced against the very real rights of our evolutionary cousins."
“Good patients” Cover Their Emotional Cracks
Shara Yurkiewicz, Scientific American
"We are kidding ourselves if we think that patients don’t sense this timing crapshoot: when it’s okay to show emotional cracks and when it is deemed a nuisance. So they decide not to show them at all."
‘Corrective Action’ in Markingson Trial Case
Cody Nelson & Katherine Lym, Minnesota Daily
"A state board has issued 'corrective action' against the University of Minnesota study coordinator in a 2003 research trial that led to the suicide of participant Dan Markingson."